Vancouver, British Columbia--(Newsfile Corp. - May 27, 2022) - Rakovina Therapeutics Inc. (TSXV: RKV) - The biotechnology company is developing precision medicines that selectively target and kill cancer cells using leading-edge science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types.
If you cannot view the video above, please visit:
https://b-tv.com/rakovina-therapeutics-transform-extend-the-lives-of-patients-with-cancer-btv-investing-news-ceo-clip-60sec/.
Rakovina Therapeutics Inc. (TSXV: RKV)
https://www.rakovinatherapeutics.com/
About CEO Clips:
CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 60 second video profiles broadcast on national TV and online via 12 financial sites including: Thomson Reuters, Bloomberg, Yahoo! Finance and Stockhouse.com.
BTV - Business Television/CEO Clips
Discover Companies to Invest in
Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/125635
